Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

21
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

25
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

488
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

26
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

27
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
27
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

418
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
418

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multifunctional polyacrylamide-gelatin deep eutectic gel with integrated antibacterial, antifreezing, and conductive properties for wearable motion sensing.

Talanta·2026
Same author

Construction of Green System for Flavonoids from <i>Dalbergia Pinnata</i> (Lour.) Prain Based on NADES-UAE: Intelligent Optimization-Molecular Mechanism-Activity Verification.

International journal of molecular sciences·2026
Same author

Integrated Physiological and Omics Analyses Reveal Endophytic Streptomyces Regulates N and P Uptake, Utilization, and Crop Productivity Enhancement.

Physiologia plantarum·2026
Same author

Correction: Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma.

Frontiers in cardiovascular medicine·2026
Same author

The future of big data and artificial intelligence on dairy farms: A proposed dairy data ecosystem.

JDS communications·2026
Same author

Cardiac metastasis mimicking acute myocardial infarction in a patient with urachal carcinoma: a case report and diagnostic dilemma.

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: Aug 27, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled

Guangming Pan1, Weiqiang Ji2, Xia Wang1

  • 1Guangdong Provincial Hospital of Chinese Medicine; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

ESC Heart Failure
|September 30, 2022
PubMed
Summary

This study shows that a multifaceted management program integrating traditional Chinese medicine (TCM) and Western medicine significantly improved chronic heart failure (CHF) patient outcomes. The integrated approach enhanced functional classification and reduced hospital readmissions for CHF patients.

Keywords:
Chronic heart failureImplementationOptimizationRandomized controlled trialTraditional Chinese medicine

More Related Videos

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

858
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

317

Related Experiment Videos

Last Updated: Aug 27, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

858
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

317

Area of Science:

  • Cardiology
  • Integrative Medicine
  • Public Health

Background:

  • Chronic heart failure (CHF) presents a significant global health challenge, necessitating innovative management strategies.
  • The integration of Traditional Chinese Medicine (TCM) with conventional Western medicine offers a promising avenue for optimizing CHF care.
  • A novel clinical pathway based on integrated TCM and Western medicine for CHF management has been developed.

Purpose of the Study:

  • To assess the implementation effects of a multifaceted optimization management program for chronic heart failure (CHF).
  • To evaluate the efficacy of an integrated approach combining usual care with Traditional Chinese Medicine (TCM) treatment.
  • To compare the outcomes of the optimization program against conventional care in CHF patients.

Main Methods:

  • Nine physicians in the optimization group received multifaceted interventions, including training, a written program, supervision, and performance monitoring.
  • Nine physicians in the control group provided conventional care (usual care) without the multifaceted intervention.
  • 256 CHF patients were randomly assigned to either the optimization program (integrated care) or the conventional program (usual care) for 24 weeks.

Main Results:

  • The optimization group showed superior improvements in New York Heart Association (NYHA) functional classification at multiple time points (12, 16, 20, and 24 weeks).
  • Significant benefits were observed in reduced readmission rates for major adverse cardiovascular events (MACEs) and worsening heart failure.
  • Improvements were also noted in plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, left ventricular ejection fraction (LVEF), TCM syndrome scores, and quality of life.

Conclusions:

  • The multifaceted optimization program is feasible and beneficial for patients with CHF.
  • The program improves NYHA functional classification, reduces heart failure readmissions, and enhances key clinical markers like NT-proBNP and LVEF.
  • It also positively impacts TCM syndrome scores, quality of life, and adherence to evidence-based measures for heart failure with reduced ejection fraction (HFrEF).